Nuvasive Inc Quick Ratio (NUVA) starting from the second quarter 2023 to second quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Nuvasive Inc  (NASDAQ: NUVA)

Nuvasive Inc's Quick Ratio

NUVA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2023, Quick Ratio deteriorated to 0.14 a new company low.

Within Medical Equipment & Supplies industry 204 other companies have achieved higher Quick Ratio than Nuvasive Inc in second quarter 2023. While Quick Ratio total ranking in the second quarter 2023 has deteriorated compared to the prior quarter from 3024 to 3919.

Explain Quick Ratio?
How much Cash & cash equivalents NUVA´s has?
What are NUVA´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NUVA Quick Ratio (Jun 30 2023)
Q2		 (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2
Y / Y Current Liabilities Change -16.94 % 171.3 % 33.4 % 256.98 % 262.02 %
Y / Y Cash & cash equivalent Change -64.28 % -11.74 % 1.05 % 1.25 % 10.7 %
Quick Ratio MRQ 0.14 0.27 0.93 0.34 0.32
NUVA's Total Ranking # 3919 # 3024 # 1386 # 2781 # 3305
Seq. Current Liabilities Change -13.67 % 151.8 % -61.57 % -0.56 % 181.98 %
Seq. Cash & cash equivalent Change -55.45 % -27.13 % 4.7 % 5.1 % 10.07 %



Quick Ratio second quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 205
Healthcare Sector # 1026
Overall Market # 3919


Quick Ratio Statistics
High Average Low
3.59 1.18 0.14
(Dec 31 2015)   (Jun 30 2023)




Financial Statements
Nuvasive Inc's Current Liabilities $ 583 Millions Visit NUVA's Balance sheet
Nuvasive Inc's Cash & cash equivalent $ 81 Millions Visit NUVA's Balance sheet
Source of NUVA's Sales Visit NUVA's Sales by Geography


Cumulative Nuvasive Inc's Quick Ratio

NUVA's Quick Ratio for the trailling 12 Months

NUVA Quick Ratio

 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth 65.1 % 179.18 % 135.07 % 26.03 % -35.64 %
Y / Y Cash & cash equivalent TTM Growth -17.97 % 0.36 % -0.13 % -46.26 % -62.78 %
Quick Ratio TTM 0.34 0.38 0.48 0.49 0.68
Total Ranking TTM # 4590 # 2544 # 4199 # 1594 # 4169
Seq. Current Liabilities TTM Growth -5.07 % 22.24 % 3.63 % 37.29 % 60.52 %
Seq. Cash & cash equivalent TTM Growth -16.26 % -2.63 % 0.28 % 0.32 % 2.45 %

Quick ratio ranking by company, industry and sector >> Back to NUVA Financial Strength Comparisons >> Go to Compare NUVA Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in NUVA's Current Liabilities to $582.58 millions, cumulative Quick Ratio to 0.34 below the NUVA average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 241 other companies have achieved higher Quick Ratio than Nuvasive Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2023 from 2544 to 4590.

Explain Quick Ratio?
How much Cash & cash equivalents NUVA´s has?
What are NUVA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 242
Healthcare Sector # 1160
Within the Market # 4590


trailing twelve months Quick Ratio Statistics
High Average Low
2.91 1.12 0.28
(Dec 31 2015)   (Jun 30 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2023, within Medical Equipment & Supplies Industry Quick RatioJun 30 2023 MRQ Cash & cash equivalentJun 30 2023 MRQ Current Liabilities
Streamex Corp   0.38 $ 1.252  Millions$ 3.332  Millions
Interpace Biosciences Inc   0.37 $ 5.079  Millions$ 13.565  Millions
Avinger Inc   0.37 $ 7.127  Millions$ 19.339  Millions
Escalon Medical Corp   0.35 $ 0.890  Millions$ 2.512  Millions
Venus Concept Inc   0.35 $ 6.122  Millions$ 17.342  Millions
Zimvie Inc   0.35 $ 66.212  Millions$ 189.740  Millions
Heartsciences Inc   0.32 $ 0.576  Millions$ 1.827  Millions
Atrion Corporation  0.31 $ 5.132  Millions$ 16.428  Millions
Resmed Inc   0.30 $ 227.891  Millions$ 758.533  Millions
Smiledirectclub Inc   0.30 $ 28.934  Millions$ 96.818  Millions
Baxter International Inc   0.30 $ 1,722.000  Millions$ 5,765.000  Millions
Bausch and Lomb Corp  0.29 $ 384.000  Millions$ 1,325.000  Millions
Masimo Corp  0.28 $ 150.700  Millions$ 531.000  Millions
Electromedical Technologies Inc   0.28 $ 0.416  Millions$ 1.483  Millions
Guided Therapeutics Inc   0.28 $ 1.358  Millions$ 4.936  Millions
Orthofix Medical Inc   0.27 $ 37.607  Millions$ 141.804  Millions
Intelligent Bio Solutions Inc   0.26 $ 1.537  Millions$ 5.884  Millions
Nu med Plus Inc   0.25 $ 0.030  Millions$ 0.118  Millions
Dih Holding Us Inc   0.25 $ 0.762  Millions$ 3.067  Millions
Steris Plc  0.24 $ 208.614  Millions$ 852.498  Millions
T2 Biosystems Inc   0.24 $ 16.084  Millions$ 66.056  Millions
P3 Health Partners Inc   0.24 $ 59.924  Millions$ 250.400  Millions
Dentsply Sirona Inc   0.23 $ 295.000  Millions$ 1,271.000  Millions
Stryker Corp  0.22 $ 1,478.000  Millions$ 6,584.000  Millions
Stimcell Energetics Inc   0.22 $ 0.098  Millions$ 0.445  Millions
Dror Ortho-Design, Inc.  0.21 $ 0.027  Millions$ 0.127  Millions
Integer Holdings Corporation  0.20 $ 38.615  Millions$ 189.757  Millions
Global Innovative Platforms Inc.  0.20 $ 0.048  Millions$ 0.242  Millions
Petvivo Holdings Inc   0.17 $ 0.246  Millions$ 1.465  Millions
Bioventus Inc   0.16 $ 29.389  Millions$ 179.104  Millions

Date modified: 2026-09-12T06:12:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.